R35 GM144117/GM/NIGMS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2022	2
2023	6
2024	2
2025	3

1

Accelerating diabetic wound healing by ROS-scavenging lipid nanoparticle-mRNA formulation.

Wang S, Zhang Y, Zhong Y, Xue Y, Liu Z, Wang C, Kang DD, Li H, Hou X, Tian M, Cao D, Wang L, Guo K, Deng B, McComb DW, Merad M, Brown BD, Dong Y. Wang S, et al. Proc Natl Acad Sci U S A. 2024 May 28;121(22):e2322935121. doi: 10.1073/pnas.2322935121. Epub 2024 May 21. Proc Natl Acad Sci U S A. 2024. PMID: 38771877 Free PMC article.

2

LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing.

Xue Y, Zhang Y, Zhong Y, Du S, Hou X, Li W, Li H, Wang S, Wang C, Yan J, Kang DD, Deng B, McComb DW, Irvine DJ, Weiss R, Dong Y. Xue Y, et al. Nat Commun. 2024 Jan 25;15(1):739. doi: 10.1038/s41467-024-45094-5. Nat Commun. 2024. PMID: 38272900 Free PMC article.

3

Close the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and dendritic cell therapy.

Zhang Y, Hou X, Du S, Xue Y, Yan J, Kang DD, Zhong Y, Wang C, Deng B, McComb DW, Dong Y. Zhang Y, et al. Nat Nanotechnol. 2023 Nov;18(11):1364-1374. doi: 10.1038/s41565-023-01453-9. Epub 2023 Jul 27. Nat Nanotechnol. 2023. PMID: 37500773 Free PMC article.

4

Adoptive cell therapy for cancer treatment.

Du S, Yan J, Xue Y, Zhong Y, Dong Y. Du S, et al. Exploration (Beijing). 2023 Jul 2;3(4):20210058. doi: 10.1002/EXP.20210058. eCollection 2023 Aug. Exploration (Beijing). 2023. PMID: 37933232 Free PMC article.

5

Biomaterials for in situ cell therapy.

Wang C, Wang S, Kang DD, Dong Y. Wang C, et al. BMEmat. 2023 Sep;1(3):e12039. doi: 10.1002/bmm2.12039. Epub 2023 Jul 19. BMEmat. 2023. PMID: 39574564 Free PMC article.

6

LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment.

Xue Y, Hou X, Zhong Y, Zhang Y, Du S, Kang DD, Wang L, Wang C, Li H, Wang S, Liu Z, Tian M, Guo K, Cao D, Deng B, McComb DW, Purisic E, Dai J, Hamon P, Brown BD, Tsankova NM, Merad M, Irvine DJ, Weiss R, Dong Y. Xue Y, et al. Nat Commun. 2025 Mar 4;16(1):2198. doi: 10.1038/s41467-025-57149-2. Nat Commun. 2025. PMID: 40038251 Free PMC article.

7

Unlock the sustained therapeutic efficacy of mRNA.

Cao D, Tian M, Liu Z, Guo K, Peng J, Ravichandra A, Ferrell C, Dong Y. Cao D, et al. J Control Release. 2025 Jul 10;383:113837. doi: 10.1016/j.jconrel.2025.113837. Epub 2025 May 12. J Control Release. 2025. PMID: 40368188 Review.

8

Advances in engineering and delivery strategies for cytokine immunotherapy.

Bohmer M, Xue Y, Jankovic K, Dong Y. Bohmer M, et al. Expert Opin Drug Deliv. 2023 May;20(5):579-595. doi: 10.1080/17425247.2023.2208344. Epub 2023 May 3. Expert Opin Drug Deliv. 2023. PMID: 37104673 Free PMC article.

9

Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.

Kang DD, Li H, Dong Y. Kang DD, et al. Adv Drug Deliv Rev. 2023 Aug;199:114961. doi: 10.1016/j.addr.2023.114961. Epub 2023 Jun 14. Adv Drug Deliv Rev. 2023. PMID: 37321375 Free PMC article. Review.

10

Nanomaterials-Mediated Co-Stimulation of Toll-Like Receptors and CD40 for Antitumor Immunity.

Yan J, Zhang Y, Du S, Hou X, Li W, Zeng C, Zhang C, Cheng J, Deng B, McComb DW, Zhao W, Xue Y, Kang DD, Cheng X, Dong Y. Yan J, et al. Adv Mater. 2022 Nov;34(47):e2207486. doi: 10.1002/adma.202207486. Epub 2022 Oct 17. Adv Mater. 2022. PMID: 36121735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year